Skip to main content

Insurance Denial and Step Therapy

Role Play & Communication · 8 minMMIHard

Answer the question

Answer out loud against the clock, or type your key points.

Insurance Denial and Step Therapy

You are a third-year medical student on an internal medicine rotation. A 45-year-old patient with newly diagnosed multiple sclerosis has been prescribed a disease-modifying therapy by the attending neurologist. The insurance company has denied the claim, requiring the patient to first try and fail two older, less effective agents -- a process called step therapy. The patient is tearful and afraid her condition will worsen during the months it takes to complete step therapy. Your attending is busy. What steps can you take, and what have you learned about the tension between clinical best practice and insurance cost management?

Likely follow-ups
  1. 1What is step therapy, and what is the clinical argument for and against it in a condition like multiple sclerosis?
  2. 2What resources exist within a hospital system to help patients navigate insurance denials?
  3. 3How do you support a patient emotionally when the healthcare system is failing them?

Speak it out loud and we'll type it for you (free), or type your own notes — then mark yourself below.

We check your answer as you go: speaking time, structure, examples and filler words.0 words
Resources & frameworks
  • SPIKES for breaking bad news: Setting, Perception, Invitation, Knowledge, Empathy, Strategy.
  • Listen → empathise → check understanding → agree a plan together. Calm voice, no jargon.
What strong answers do
Reveal the benchmark

Hidden so they don't bias your answer. Score yourself first, then reveal them to compare.

  • As a student your authority is limited but your responsibility is not zero: notify your attending, contact the patient financial counselor or case manager, and ask the manufacturer's patient support program about medication bridges or prior authorization help.
  • Explain step therapy accurately and concede its cost-control logic before showing why it sits badly with MS, where DMT efficacy depends on early, aggressive treatment and delays risk irreversible neurological damage. Argue on clinical grounds: request a peer-to-peer review and document the evidence in the appeal.
  • Do not promise an outcome you cannot deliver. Name her fear, be honest about what is and is not in your control, and tell her who is working on the appeal and when she will hear back.

Mark yourself

Score each skill against the question's mark scheme, then add a line of evidence.

Scale0Not shown1Emerging2Solid3Strong
Quick mark:
Completion: 0%

Patient Advocacy

Look for: Identifies concrete steps to support the patient within the student role

0/3

Communication

Look for: Demonstrates how to acknowledge systemic failure while maintaining therapeutic presence

0/3

Health Policy Literacy

Look for: Understands step therapy and its clinical implications

0/3

Teamwork

Look for: Activates the appropriate hospital network rather than acting alone

0/3

Reflect & score

Note what you'd change, then give the whole answer a mark out of 10.

Your overall score / 10

Not scored yet

Your results

Mark yourself first, then reveal the model answer to compare.

Your score, charted against a model answer

  • Score ring and verdict
  • Skills radar, you vs the model
  • Strongest skill and next step
  • Checks on your wording
Total: 0/12
Saved